Amgen shares dropped on Monday after the firm released additional data from its early-stage lung cancer study. Specifically this data is coming from the ongoing Phase 1 study evaluating AMG 510 in patients with…
Eli Lilly shares dipped on Monday after the firm announced results from its midstage clinical trial for the treatment of lung cancer.
A 43-year-old Indonesian man is walking 435 miles, from his home in East Java to the capital of Jakarta — backwards. Covering about 12 to 19 miles a day, with a rear-view mirror attached…
Acadia Pharmaceuticals shares rose sharply early Monday after the firm announced that its late-stage dementia study met its primary endpoint.
Endo shares jumped on Friday after the company announced that it has submitted a Biologics License Application to the FDA for collagenase clostridium histolyticum for the treatment of cellulite in the buttocks.
An estimated 1.8 million children in the U.S. have a potentially life-threatening allergy to peanuts. (According to the National Institutes of Health, little is known about peanut allergies in adults.) The culprit in allergic…
NextCure appears to be one of those companies that has flown under the radar of the investing community since its initial public offering in 2019.
While just announced huge deal seems to be the big break that Cidara Therapeutics needs, one analyst believes this stock could nearly double in the next 12 months.
GBT shares jumped on Thursday after the company announced that the FDA has accepted for filing the company’s New Drug Application for voxelotor as a treatment of sickle cell disease.
Shares of drugmaker Mallinckrodt have lost more than 40% overnight following reports that the firm has hired restructuring advisors. A bankruptcy filing is a real possibility.
A popular pain-killer, generally considered safe and effective, can turn toxic and even deadly if it’s overused — a concern amplified by a study of the possible deadly effects of the drug published earlier…
Puma Biotechnology shares jumped early Wednesday after FDA news about Puma’s breast cancer treatment. However, Puma shares quickly fell off from this FDA sugar high.
Ardelyx shares jumped on Tuesday after the firm announced positive results from its late-stage study in dialysis patients who have uncontrolled hyperphosphatemia.
Following more than 200 reports of respiratory illness and one death possibly linked to using e-cigarettes, the U.S. FDA and CDC are stepping up their investigation into the use of the devices and the…
Cidara Therapeutics shares saw a massive gain on Tuesday after the firm announced that it has entered into a strategic partnership with Mundipharma to develop and commercialize Cidara’s treatment for invasive fungal infections.
